CEO
Nassim Usman
Employees
35
Industry
Pharmaceutical Preparation Manufacturing
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Loading...
Open
0.57
Mkt cap
19M
Volume
461K
High
0.58
P/E Ratio
-0.02
52-wk high
8.69
Low
0.48
Div yield
N/A
52-wk low
0.19
Portfolio Pulse from Lisa Levin
September 05, 2023 | 5:34 pm
Portfolio Pulse from Benzinga Insights
September 04, 2023 | 5:31 pm
Portfolio Pulse from Benzinga Insights
September 01, 2023 | 5:31 pm
Portfolio Pulse from Benzinga Insights
August 25, 2023 | 9:31 pm
Portfolio Pulse from Lisa Levin
August 17, 2023 | 4:26 pm
Portfolio Pulse from Benzinga Insights
August 16, 2023 | 5:31 pm
Portfolio Pulse from Benzinga Insights
August 14, 2023 | 2:44 pm
Portfolio Pulse from Lisa Levin
July 20, 2023 | 5:26 pm
Portfolio Pulse from Lisa Levin
June 22, 2023 | 11:51 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.